This article discusses the importance of collaboration among G20 nations in conducting clinical trials on infectious diseases. The authors conducted a bibliometric analysis of studies published by G20-affiliated authors between 2010 and 2022. The results showed that the United States, the United Kingdom, and Germany had the most publications, while India ranked 13th. The study also highlighted the need for increased funding and research on viral infections such as HIV/AIDS, COVID-19, and hepatitis. The authors suggest that global leadership through entities like the G20 is necessary to enhance future research and address infectious disease threats. [Extracted from the article]